- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Metastatic or locally advanced basal cell carcinoma (BCC)
- Meeting Date: July 2023
- Public Summary Document (PSD) July 2023 PBAC Meeting - (PDF 334KB)
- Public Summary Document (PSD) July 2023 PBAC Meeting - (Word 94KB)
Sonidegib – July 2023
Sonidegib: Capsule 200 mg; Odomzo®
Last updated
27 October 2023